You are here
A Solid Phase Assay for Topoisomerase I interfacial Poisons and Catalytic Inhibitors
- Date Issued:
- 2011
- Abstract/Description:
- We report a mechanism based screening technique to rapidly identify eukaryotic topoisomerase I targeting agents. The method is based on genetic tagging of topoisomerase I to immobilize the enzyme on a solid surface in a microtiter well format. DNA is added to the wells and retained DNA is detected by Picogreen fluorescence. Compounds that result in an increase in Picogreen staining represent potential topoisomerase interfacial poisons while those that reduce fluorescence report catalytic inhibitors; therefore, the solid phase assay represents a 'bimodal' readout that reveals mechanisms of action. The method has been demonstrated to work with known interfacial poisons and catalytic inhibitors. In addition to specific topoisomerase targeting drugs, the method also weakly detects other relevant anticancer agents, such as potent DNA alkylating and intercalating compounds; therefore, topoisomerase I HTS represents an excellent tool for searching and identifying novel genotoxic agents. This method is rapid, robust, economical and scalable for large library screens.
Title: | A Solid Phase Assay for Topoisomerase I interfacial Poisons and Catalytic Inhibitors. |
37 views
19 downloads |
---|---|---|
Name(s): |
Cyril Sagayaraj, Vidusha, Author Muller, Mark, Committee Chair Zhao, Jihe, Committee Member Chakrabarti, Debopam, Committee Member , Committee Member University of Central Florida, Degree Grantor |
|
Type of Resource: | text | |
Date Issued: | 2011 | |
Publisher: | University of Central Florida | |
Language(s): | English | |
Abstract/Description: | We report a mechanism based screening technique to rapidly identify eukaryotic topoisomerase I targeting agents. The method is based on genetic tagging of topoisomerase I to immobilize the enzyme on a solid surface in a microtiter well format. DNA is added to the wells and retained DNA is detected by Picogreen fluorescence. Compounds that result in an increase in Picogreen staining represent potential topoisomerase interfacial poisons while those that reduce fluorescence report catalytic inhibitors; therefore, the solid phase assay represents a 'bimodal' readout that reveals mechanisms of action. The method has been demonstrated to work with known interfacial poisons and catalytic inhibitors. In addition to specific topoisomerase targeting drugs, the method also weakly detects other relevant anticancer agents, such as potent DNA alkylating and intercalating compounds; therefore, topoisomerase I HTS represents an excellent tool for searching and identifying novel genotoxic agents. This method is rapid, robust, economical and scalable for large library screens. | |
Identifier: | CFE0004473 (IID), ucf:49304 (fedora) | |
Note(s): |
2011-12-01 M.S. Medicine, Molecular Biology and Microbiology Masters This record was generated from author submitted information. |
|
Subject(s): | Eukaryotic topoisomerase I -- High-Throughput screening -- Solid Phase Assay -- Anti cancer compounds -- DNA binding proteins | |
Persistent Link to This Record: | http://purl.flvc.org/ucf/fd/CFE0004473 | |
Restrictions on Access: | campus 2013-06-15 | |
Host Institution: | UCF |